Category: Insights for investors

Infermedica expands company’s API capabilities to include AI-driven patient intake workflows

We are happy to introduce our new API for Intake, which improves patient care, reduces clinician burnout, and delivers intake data prior to care.

Infermedica 2022: Year in Review

A roundup of what we’ve accomplished in 2022, and what’s next in 2023.

Techniker Krankenkasse launches Infermedica’s symptom checker

A German health insurer expands its offer with a symptom checker, a new tool based on Infermedica Triage, to empower its members.

Infermedica named to the 2022 CB Insights’ Digital Health 150 List

We’re pleased to announce that CB Insights named Infermedica to its fourth-annual Digital Health 150, showcasing the 150 most promising private digital health companies of 2022.

Infermedica announces the Medical Guidance Platform

Read how Infermedica’s AI-powered Medical Guidance Platform tackles the biggest problems facing healthcare systems to support patients and providers.

Infermedica wins “Best Healthcare Information Destination” MedTech Breakthrough Award

We’re honored to be recognized as the “Best Healthcare Information Destination” in the MedTech Breakthrough Awards.

Ramsay Santé: A hospital offering patients a personalized connection to medical services

See how Ramsay Santé, Europe’s second-largest private healthcare provider, leverages symptom checkers for patient navigation and connection to services.

GoGetDoc: From digital symptom check to consultation

See how GoGetDoc used a simple symptom checker to build effective healthcare communication and engagement with patients.